Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-15.46%
operating margin TTM
-75.47%
revenue TTM
303.73 Million
revenue per share TTM
4.23$
valuation ratios | |
|---|---|
| pe ratio | -7.80 |
| peg ratio | -0.08 |
| price to book ratio | 0.10 |
| price to sales ratio | 1.20 |
| enterprise value multiple | -5.94 |
| price fair value | 0.10 |
profitability ratios | |
|---|---|
| gross profit margin | 67.87% |
| operating profit margin | -75.47% |
| pretax profit margin | -67.9% |
| net profit margin | -15.46% |
| return on assets | -0.69% |
| return on equity | -0.91% |
| return on capital employed | -4.11% |
liquidity ratios | |
|---|---|
| current ratio | 4.59 |
| quick ratio | 4.53 |
| cash ratio | 0.75 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 277.53 |
| operating cycle | 573.58 |
| days of payables outstanding | 47.75 |
| cash conversion cycle | 525.82 |
| receivables turnover | 1.23 |
| payables turnover | 7.64 |
| inventory turnover | 1.32 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.06 |
| debt equity ratio | 0.11 |
| long term debt to capitalization | 0.06 |
| total debt to capitalization | 0.10 |
| interest coverage | -29.67 |
| cash flow to debt ratio | -1.01 |
cash flow ratios | |
|---|---|
| free cash flow per share | -7.78 |
| cash per share | 92.39 |
| operating cash flow per share | -7.10 |
| free cash flow operating cash flow ratio | 1.10 |
| cash flow coverage ratios | -1.01 |
| short term coverage ratios | -2.19 |
| capital expenditure coverage ratio | -10.44 |
Frequently Asked Questions
When was the last time Sinovac Biotech Ltd. (NASDAQ:SVA) reported earnings?
Sinovac Biotech Ltd. (SVA) published its most recent earnings results on 31-12-2023.
What is Sinovac Biotech Ltd.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Sinovac Biotech Ltd. (NASDAQ:SVA)'s trailing twelve months ROE is -0.91%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Sinovac Biotech Ltd. (SVA) currently has a ROA of -0.69%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did SVA's net profit margin stand at?
SVA reported a profit margin of -15.46% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is SVA's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 4.59 in the most recent quarter. The quick ratio stood at 4.53, with a Debt/Eq ratio of 0.11.